Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate “Tripartisan” Medicare Rx Drug Bill To Have 50% Copay, $35 Premium

Executive Summary

The Medicare prescription drug bill under development by a five-member "tripartisan" coalition within the Senate Finance Committee includes a 50% copay and a $35 monthly premium
Advertisement

Related Content

Rx Cost-Effectiveness Data Requirement Would Raise Prices – AstraZeneca
Rx Cost-Effectiveness Data Requirement Would Raise Prices – AstraZeneca
Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
Senate Change Puts Hatch, Gregg, Grassley In Line For Key Rx Committees
Compromise Medicare Rx Benefit Will Be Next Step For Senate, Daschle Says
Compromise Medicare Rx Benefit Will Be Next Step For Senate, Daschle Says
Medicare Rx Clears House; Late Changes Include Nod To Pharmacy
Medicare Rx Clears House; Late Changes Include Nod To Pharmacy
PBM Quality Comparisons Feature In Senate Dems’ Medicare Rx Bill
Advertisement
UsernamePublicRestriction

Register

PS040136

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel